Celgene Reports Third Quarter 2018 Operating and Financial Results

Go back to Celgene Reports Third Quarter 2018 Operating and Financial Results

Celgene (CELG) Tops Q3 EPS by 7c, Updates Guidance

October 25, 2018 7:31 AM EDT

Celgene (NASDAQ: CELG) reported Q3 EPS of $2.29, $0.07 better than the analyst estimate of $2.22. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.83 billion.

GUIDANCE:

Celgene sees FY2018 EPS of $8.75-$8.80, versus the consensus of $8.76. Celgene sees... More